|
PUM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.45869999999848E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.602600E-04 |
| Normal-vs-Stage2 |
2.083600E-02 |
| Normal-vs-Stage3 |
2.12059999999958E-05 |
| Normal-vs-Stage4 |
1.51190999999606E-05 |
| Stage1-vs-Stage2 |
7.714400E-01 |
| Stage1-vs-Stage3 |
1.404170E-01 |
| Stage1-vs-Stage4 |
3.652300E-02 |
| Stage2-vs-Stage3 |
2.181600E-01 |
| Stage2-vs-Stage4 |
1.084400E-01 |
| Stage3-vs-Stage4 |
5.170400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.29159999999284E-05 |
| Normal-vs-AfricanAmerican |
5.245200E-01 |
| Normal-vs-Asian |
7.609800E-04 |
| Caucasian-vs-AfricanAmerican |
2.648200E-02 |
| Caucasian-vs-Asian |
8.089200E-01 |
| AfricanAmerican-vs-Asian |
4.498400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.420800E-04 |
| Normal-vs-Female |
6.27069999999952E-05 |
| Male-vs-Female |
7.168200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.356360E-03 |
| Normal-vs-Age(41-60Yrs) |
2.354300E-04 |
| Normal-vs-Age(61-80Yrs) |
3.5913000000054E-05 |
| Normal-vs-Age(81-100Yrs) |
1.283610E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.849400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.833790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.956000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.884000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.737200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.443000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.097900E-03 |
| Classical-VS-Follicular |
9.643200E-01 |
| Classical-VS-Other |
5.398400E-01 |
| Classical-VS-Normal |
5.615400E-04 |
| Tall-VS-Follicular |
1.915610E-02 |
| Tall-VS-Other |
5.355200E-01 |
| Tall-VS-Normal |
3.47820000001775E-06 |
| Follicular-VS-Other |
5.774800E-01 |
| Follicular-VS-Normal |
6.576600E-03 |
| Other-VS-Normal |
6.250200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.405300E-04 |
| Normal-vs-N1 |
6.12079999999793E-05 |
| N0-vs-N1 |
2.180800E-01 |
|
|
